nach oben

Erschienen in:

01.11.2013 | Original Paper

Test of a Web-Based Program to Improve Adherence to HIV Medications

verfasst von: Rebekah K. Hersch, Royer F. Cook, Douglas W. Billings, Seth Kaplan, David Murray, Steven Safren, Justin Goforth, Joy Spencer

Erschienen in: AIDS and Behavior | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

We evaluated the effectiveness of a web-based version of the Life-Steps intervention combined with modules for stress reduction and mood management, designed to improve medication adherence among HIV infected individuals. 168 HIV+ adults were randomized into either the Life-Steps program or a waitlist control condition. All participants completed a baseline assessment and provided a 2-week electronic pill (MEMS) cap baseline reading. Follow up data collection was conducted at 3, 6 and 9 months. Patients in the web-based Life-Steps condition had significantly higher antiretroviral medication adherence rates than patients in the control group over the nine-month period as measured by the MEMS cap. In addition, analysis of viral load data indicated that the program also resulted in a significant decrease in viral load. These findings indicate that a web-based Life-Steps program can be a useful and implementable tool for helping patients living with HIV maintain medication adherence.

O’Cleirigh C, Safren S. Optimizing the effects of stress management interventions in HIV. Health Psychol. 2008;27:4–14.CrossRef

Safren SA, Otto MW, Worth J, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39:1151–62.PubMedCrossRef

Safren SA, O’Cleirigh CM, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1–10.PubMedCrossRef

Carpenter CJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the international AIDS society-USA panel. JAMA. 1997;277:1962–9.PubMedCrossRef

Flexner C. HIV-protease inhibitors. N Engl J Med. 1998;338(18):1281–92.PubMedCrossRef

Goebel FD. Combination therapy from a clinician’s perspective. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:S62–8.PubMedCrossRef

Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304:321–33.PubMedCrossRef

Catz SL, Kelly JA, Bogart LM, et al. Patterns, correlates a barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124–33.PubMedCrossRef

Hinkin CH, Barclay TR, Castellon SA, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11(2):185–94.PubMedCrossRef

10.

Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.PubMedCrossRef

11.

Scott-Sheldon LAJ, Carey MP, Vanable PA, Senn TE, Coury-Doniger P, Urban MA. Alcohol consumption, drug use, and condom use among STD clinic patients. J Stud Alcohol Drugs. 2009;70:762–70.PubMed

12.

Safren SA, Otto MW, Worth J. Life-steps: applying cognitive-behavioral therapy to patient adherence to HIV medication treatment. Cogn Behav Pract. 1999;6:332–41.CrossRef

13.

Safren SA, Hendriksen ES, DeSousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003;15:787–93.PubMedCrossRef

14.

Safren SA, Hendriksen ES, Mayer KH, Pickard R, Otto MW. Cognitive behavioral therapy for HIV medication adherence and depression. Cogn Behav Pract. 2004;11:415–23.CrossRef

15.

Simoni JS, Amico KR, Pearson CR. Malow RM Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Cogn Behav Pract. 2008;10:515–21.

16.

Cook RF, Billings DW, Hersch RK, Back A, Hendrickson A. A field test of a web-based workplace health promotion program to improve dietary practices, reduce stress, and increase physical activity: randomized controlled trial. J Med Internet Res. 2007;9:e17.PubMedCrossRef

17.

Portnoy DB, Scott-Sheldon LAJ, Johnson BT, Carey MP. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47:3–16.PubMedCrossRef

18.

Williams GC, Lynch MF, Glasgow RE. Computer-assisted intervention improves patient-centered diabetes care by increasing autonomy support. Health Psychol. 2007;26:728–34.PubMedCrossRef

19.

Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23:107–15.PubMedCrossRef

20.

Fisher JD, Amico KR, Fisher WA, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows project. AIDS Behav. 2011;15(8):1635–46.PubMedCrossRef

21.

Billings DW, Cook RF, Hendrickson A, Dove DC. A web-based approach to managing stress and mood disorders in the workforce. J Occup Environ Med. 2008;50:960–8.PubMedCrossRef

22.

Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care. 2000;12:255–66.PubMedCrossRef

23.

Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients with chronic illness. J Nurs Meas. 2007;15:207–23.CrossRef

24.

Pakenham KI, Rinaldis M. Development of the HIV/AIDS stress scale. Psychol Health. 2002;17:203–19.CrossRef

25.

Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54:1063–70.PubMedCrossRef

26.

Cook RF, Bernstein A, Andrews C. Assessing drug use in the workplace: a comparison of self-report, urinalysis and hair analysis. NIDA research monograph 167. Rockville: National Institute on Drug Abuse; 1997.

27.

Cook RF, Back AS, Trudeau J, McPherson TL. Integrating substance abuse prevention into health promotion programs in the workplace: a social-cognitive intervention targeting the mainstream user. In: Bennett JB, Lehman WEK, editors. Preventing workplace substance abuse: beyond drug testing to wellness. Washington, D.C.: APA Books; 2003. p. 97–134.CrossRef

28.

Cook RF, Hersch RK, Back AS, McPherson TL. The prevention of substance abuse among construction workers: a field test of a social cognitive program. J Prim Prev. 2004;25:337–58.CrossRef

29.

Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. New York: Springer; 2010.CrossRef

30.

Schafer JL. Analysis of incomplete multivariate data. London: Chapman and Hall; 1997.CrossRef

31.

Centers for Disease Control. Estimated HIV incidence among adults and adolescents in the United States, 2007–2010. HIV Surveillance Supplemental Report. 2012;17:4. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental.

32.

Government of the District of Columbia, Department of Health. Annual report 2011: HIV/AIDS, hepatitis, STD, and TB epidemiology of the District of Columbia. Washington, DC: Department of Health: HIV/AIDS, Hepatitis, STD, and TB Administration (HAHSTA); 2012.

33.

Centers for Disease Control. Methamphetamine use and HIV risk behaviors among heterosexual men -preliminary results from five northern California counties, December 2002–November 2003. MMWR. 2006;55:273–7.

34.

Molitor F, Truax SR, Ruiz JD, et al. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998;168:93–7.PubMed

35.

Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med. 1997;336:1072–8.PubMedCrossRef

36.

Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66.PubMedCrossRef

37.

Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlations between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.PubMedCrossRef

38.

Wagner GJ. Predictors of antiretroviral adherence as a measure by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STDS. 2002;16(12):599–608.PubMedCrossRef

39.

Deschamps AE, Van Wijngaerden E, Denhaerynck K, De Geest S, Vandamme AE. Use of electronic monitoring induces a 40-day intervention effect in HIV patients. J Acquir Immune Defic Syndr. 2006;43:247–8.PubMedCrossRef

40.

Zickuhr K, Smith, A. Digital differences. Washington, DC: Pew Research Center’s Internet and American Life Project. 2012. pewinternet.org/Reports/2012/Digital-differences.aspx.

41.

Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25(6):825–34.PubMedCrossRef

Titel: Test of a Web-Based Program to Improve Adherence to HIV Medications
verfasst von: Rebekah K. Hersch
Royer F. Cook
Douglas W. Billings
Seth Kaplan
David Murray
Steven Safren
Justin Goforth
Joy Spencer
Publikationsdatum: 01.11.2013
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 9/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-013-0535-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2013

Developing an Online Health Intervention for Young Gay and Bisexual Men

Who is Omitted from Repeated Offline HIV Behavioural Surveillance Among MSM? Implications for Interpreting Trends

A Randomized Trial of a Behavioral Intervention for High Risk Substance-Using MSM

To Weight or Not to Weight in Time-location Sampling: Why Not Do Both?

A Comparison Study of Methods for Measuring Retention in HIV Medical Care